Five things for pharma marketers to know: Thursday, August 23, 2018

Five things for pharma marketers to know: Thursday, August 23, 2018

Trump's conflicting policies on PBMs confuse the industry; Pfizer strikes deal to co-promote Cologuard; Tech company develops microchip for dementia patients.

Five things for pharma marketers to know: Wednesday, August 21, 2018

Five things for pharma marketers to know: Wednesday, August 21, 2018

FDA extends EpiPen expiration dates; GE Ventures senior managing director departs; Facebook launches MRI research project.

FCB Health looks to the future of content with Studio Rx launch

FCB Health looks to the future of content with Studio Rx launch

Studio Rx will offer services in experiential media like virtual and augmented reality, 360-degree video, and installations.

Five things for pharma marketers to know: Tuesday, August 21, 2018

Five things for pharma marketers to know: Tuesday, August 21, 2018

FDA gives Keytruda new real-time approval; AstraZeneca headquarters construction boondoggle; Lack of sleep costs U.S. economy hundreds of billions per year.

Novo Nordisk's Ozempic takes on Lilly's Trulicity in DTC showdown

Novo Nordisk's Ozempic takes on Lilly's Trulicity in DTC showdown

The two diabetes rivals air competing TV spots as they compete for GLP-1 supremacy.

Five things for pharma marketers to know: Monday, August 20, 2018

Five things for pharma marketers to know: Monday, August 20, 2018

Azar says HHS can eliminate rebates; States pass measures to stop drug price increases; 'Poor oversight' blamed for California sitting on cash to treat mentally ill.

Evoke Group rebrands, reorganizes subsidiary agencies

Evoke Group rebrands, reorganizes subsidiary agencies

The renamed Evoke will replace the individual agency network with six areas of focus.

Five things for pharma marketers to know: Friday, August 17, 2018

Five things for pharma marketers to know: Friday, August 17, 2018

Purdue Pharma taps financial restructuring firm; White House wants opioid-production cut; NYU to make med school free.

David Gideon, medical media icon and industry stalwart, dies at 75

David Gideon, medical media icon and industry stalwart, dies at 75

For Gideon, honoring those who helped build the medical ad industry became a labor of love.

First generic version of EpiPen approved by FDA

First generic version of EpiPen approved by FDA

Teva's generic EpiPen injector received a thumbs up from the FDA on Thursday.

Study: FDA anti-tobacco campaign prevented 350,000 teens from smoking

Study: FDA anti-tobacco campaign prevented 350,000 teens from smoking

The study estimated the FDA's anti-smoking campaign, The Real Cost, saved $31 billion in smoking-related costs to society.

Five things for pharma marketers to know: Thursday, August 16, 2018

Five things for pharma marketers to know: Thursday, August 16, 2018

CDC estimates 72,000 died of drug overdoses in 2017; Genentech to lay off 200-plus employees; Pfizer invests up to $425 million in BioNTech.

Five things for pharma marketers to know: Wednesday, August 15, 2018

Five things for pharma marketers to know: Wednesday, August 15, 2018

Alphabet invests more in Oscar; ViiV's HIV injection proves effective; Gilead's chief medical officer departs in latest executive exit.

Novartis names Klaus Moosmayer ethics, risk, and compliance chief

Novartis names Klaus Moosmayer ethics, risk, and compliance chief

Moosmayer is set to join the pharma company in December.

Healix's Jeffrey Erb on what pharma giants consolidating accounts means for agencies

Healix's Jeffrey Erb on what pharma giants consolidating accounts means for agencies

Bigger budgets, fewer accounts. That's the dilemma facing pharma marketers as drugmakers consolidate work.

Five things for pharma marketers to know: Tuesday, August 14, 2018

Five things for pharma marketers to know: Tuesday, August 14, 2018

Icahn drops bid to stop Cigna-Express Scripts tie-up; Bayer joins Evotec-Haplogen partnership to find COPD treatments; Orchard raises $150 million in Series C funding.

WPP leaves Farm Street HQ as it cuts links with Sorrell era

WPP leaves Farm Street HQ as it cuts links with Sorrell era

WPP is set to depart its London headquarters in Farm Street after more than 30 years as it seeks "a more modern and attractive office."

Novartis ups Sreejit Mohan to global head of external communications

Novartis ups Sreejit Mohan to global head of external communications

Mohan was previously head of global drug-development communications.

Five things for pharma marketers to know: Monday, August 13, 2018

Five things for pharma marketers to know: Monday, August 13, 2018

Bayer shares fall after Monsanto weedkiller judgment; FDA approves first birth-control app to be marketed as contraception method; Regulators okay landmark RNAi-based therapy.

Marketing a first-of-its-kind addiction treatment amid the opioid crisis

Marketing a first-of-its-kind addiction treatment amid the opioid crisis

The first non-opioid opioid-withdrawal treatment, Lucemyra, hit the market this week.

Five things for pharma marketers to know: Friday, August 10, 2018

Five things for pharma marketers to know: Friday, August 10, 2018

FDA approves record number of generics in July; Trump drug-pricing policies may be hurting generic makers; Justice Department joins opioid lawsuit.

Outcome Health adds Nielsen measurement tools

Outcome Health adds Nielsen measurement tools

The point-of-care healthcare marketing company also conducted an initial study with Nielsen on its audience.

Five things for pharma marketers to know: Thursday, August 9, 2018

Five things for pharma marketers to know: Thursday, August 9, 2018

Rite Aid, Albertsons call off merger; AMA disapproves of CVS-Aetna deal; FDA signs off on first generic drug for CGT designation.

Kyne partners with Agora to expand reach to Latin America

Kyne partners with Agora to expand reach to Latin America

The partnership will give Kyne a presence in Mexico, Argentina, and Colombia.

Five things for pharma marketers to know: Wednesday, August 8, 2018

Five things for pharma marketers to know: Wednesday, August 8, 2018

Trump promises move to lower drug prices; CVS, Novo Nordisk beat earnings predictions; AstraZeneca settles two suits with Texas for $110 million.

Five things for pharma marketers to know: Tuesday, August 7, 2018

Five things for pharma marketers to know: Tuesday, August 7, 2018

Icahn asks Cigna investors to reject $54 billion Express Scripts deal; FDA changes opioid treatment evaluation; GSK names CFO.

Analysts: Amarin poised for huge gains if Vascepa trial comes back positive

Analysts: Amarin poised for huge gains if Vascepa trial comes back positive

Analysts from Jefferies predicted up to $2 billion in peak sales if Amarin's seven-year trial data is positive.

Five things for pharma marketers to know: Monday, August 6, 2018

Five things for pharma marketers to know: Monday, August 6, 2018

Regeneron invests $100 million in bluebird; Boehringer Ingelheim starts cystic fibrosis coalition; FDA rejects Pain Therapeutics' application to sell Remoxy.

POC community makes good on promises of transparency and accountability

POC community makes good on promises of transparency and accountability

After a scandal with one of point of care's biggest players, we examine how the community is living up to its promise of greater transparency.

Abbott Nutrition comms leader Steve Yuan joins Edelman Chicago

Abbott Nutrition comms leader Steve Yuan joins Edelman Chicago

He's filling the newly created role of EVP of integrated analytics and innovation for the agency's Chicago health practice.

Five things for pharma marketers to know: Friday, August 3, 2018

Five things for pharma marketers to know: Friday, August 3, 2018

Allergan sues Pfizer to cover costs of opioid lawsuits; Drug companies donate millions to areas hit by the opioid crisis; Mayo Clinic: Opioid prescriptions not decreasing.

Orphan drugs leveraging new tech promise to cure disease

Orphan drugs leveraging new tech promise to cure disease

Two late-stage orphan drugs are upping the ante with their promise to cure disease.

J. Walter Thompson's Alissa Kaplan on hot desking, planners, and FaceTime

J. Walter Thompson's Alissa Kaplan on hot desking, planners, and FaceTime

Alissa Kaplan, executive director, healthcare, at J. Walter Thompson, discusses work-life balance and how she manages her day.

DCI Donor Services takes the morbid out of organ donation

DCI Donor Services takes the morbid out of organ donation

The organization worked with Finn Partners to create the #BeTheGift campaign.

Five things for pharma marketers to know: Thursday, August 2, 2018

Five things for pharma marketers to know: Thursday, August 2, 2018

Lead Tecentriq scientist resigns; Apple hires for on-site health clinic; Novo launches DTC diabetes campaign.

Omnicom makes first management, tech consulting purchase

Omnicom makes first management, tech consulting purchase

Credera - like consultancies - has direct access to Fortune 500 C-suite execs.

Digital deliverance: 4 ways marketers can make content more engaging for HCPs

Digital deliverance: 4 ways marketers can make content more engaging for HCPs

Despite a rash of pessimism, HCPs remain engageable. Marketers must utilize open medical education hubs and CME town halls — among other tactics — to make content more engaging.

Haymarket Media brings on Ogilvy CommonHealth med-ed leader

Haymarket Media brings on Ogilvy CommonHealth med-ed leader

Mary Manna Anderson has joined Haymarket to lead its medical education business.

Five things for pharma marketers to know: Wednesday, August 1, 2018

Five things for pharma marketers to know: Wednesday, August 1, 2018

Pfizer CEO says rebates to go away; Ispos to acquire four GfK research divisions; Sanofi promises to return to growth in 2H 2018.

Infographic | HCPs OK with emails from marketers

Infographic | HCPs OK with emails from marketers

HCPs are still OK with hearing from pharma and medical device marketers as long as it's by email.

'Long way to go' before top pharma companies' digital presence measures up to current tech standards: study

'Long way to go' before top pharma companies' digital presence measures up to current tech standards: study

A cross section of pharma brand websites fell short across all measured areas, including consumer experience, technology, SEO, and analytics, researchers said.

GSK digital leader brings tech flair

GSK digital leader brings tech flair

GSK consumer healthcare chief digital officer Marc Speichert talks about being a builder.

Familiar names highlight Pfizer's Q2

Familiar names highlight Pfizer's Q2

Historical big earners once again performed for Pfizer in Q2, while Ibrance broke the $1 billion barrier.

Five things for pharma marketers to know: Tuesday, July 31, 2018

Five things for pharma marketers to know: Tuesday, July 31, 2018

Pfizer lowers full-year forecast; Bayer to sell prescription dermatology brands to Leo; behind July's healthcare agency M&A boom.

Global marketers expect their budgets to rise in 2019

Global marketers expect their budgets to rise in 2019

At least six in 10 marketing chiefs globally are expecting growth in their budgets in the coming year, with 73% of UK chief marketing officers predicting a boost.

Five things for pharma marketers to know: Monday, July 30, 2018

Five things for pharma marketers to know: Monday, July 30, 2018

Study: Few patients use price-comparison tools to shop for lower-limb MRIs; Ascletis raises $400 million in Hong Kong IPO; California bucks trend on maternal death rates.

Benchworks launches health system marketing division

Benchworks launches health system marketing division

The agency brought on Lisa Wolfington to lead the group as director of health system marketing.

Five things for pharma marketers to know: Friday, July 27, 2018

Five things for pharma marketers to know: Friday, July 27, 2018

AstraZeneca promises to not raise drug prices this year; EHR adoption could lower hospital death rates: study; Roche's new drugs drive earnings.

TV4 unveils streaming network dedicated to cancer

TV4 unveils streaming network dedicated to cancer

The channel will feature content about the full range of the cancer journey.

Corporate affairs head Jeff Winton departs Astellas for Alkermes

Corporate affairs head Jeff Winton departs Astellas for Alkermes

Astellas shook up its corporate affairs department after Winton's departure.

Facebook shares plunge amid first decline in European daily active users

Facebook shares plunge amid first decline in European daily active users

Facebook sought to blame GDPR as it revealed its daily active users in Europe declined for the first time in nine years and it disappointed investors with lower-than-expected growth.

Five things for pharma marketers to know: Thursday, July 26, 2018

Five things for pharma marketers to know: Thursday, July 26, 2018

Alzheimer's drug slows cognitive decline; Gilead CEO to leave; Amgen migraine drug face difficulties with insurers.

Five things for pharma marketers to know: Wednesday, July 25, 2018

Five things for pharma marketers to know: Wednesday, July 25, 2018

Full-page Purdue print ad amended; GSK partners with 23andMe; AbbVie's endometriosis drug to cost more than $10,000 per year.

Huntsworth cuts ties with 5% of PR accounts to end 'abusive' client relationships

Huntsworth cuts ties with 5% of PR accounts to end 'abusive' client relationships

Huntsworth has stopped working with around 5% of clients in its Communications arm - which includes Grayling, Red and Citigate - as it exits "unprofitable" accounts, CEO Paul Taaffe has told PRWeek.

Study: 77% of young people exposed to Truth ads don't plan to smoke

Study: 77% of young people exposed to Truth ads don't plan to smoke

The Truth Initiative surveyed 9,000 young people to determine whether its campaign was really working.

Five things for pharma marketers to know: Tuesday, July 24, 2018

Five things for pharma marketers to know: Tuesday, July 24, 2018

Commercial chief to exit Bristol-Myers Squibb; Study: Wal-Mart $4 prescription plan a more affordable option for some Medicare patients; Trump administration pushes back on antibiotic use on farm animals.

Huntsworth PR revenue falls as Grayling 'eliminates' unprofitable client contracts

Huntsworth PR revenue falls as Grayling 'eliminates' unprofitable client contracts

Huntsworth has reported a 5.4% fall in like-for-like revenue at its PR agencies in the first half of 2018, led largely by declines at Grayling after the "elimination of unprofitable client contracts."

IPG raises growth target for 2018 amid strong Q2 results

IPG raises growth target for 2018 amid strong Q2 results

The holding company's net revenue jumped 5.6% in the second quarter.

Pharma's med-ed backing rises for fourth straight year

Pharma's med-ed backing rises for fourth straight year

Data on medical education spending show a continued increase in investment from the pharma and medical device industries.

Five things for pharma marketers to know: Monday, July 23, 2018

Five things for pharma marketers to know: Monday, July 23, 2018

Bayer to stop selling Essure; FDA approves Agios' leukemia treatment; Investor lawsuit targets Theranos.

Cannes Lions revenue down 9% but marketers spending more

Cannes Lions revenue down 9% but marketers spending more

This year's Cannes Lions festival made 9% less revenue than in 2017 owing to falls in both delegate numbers and awards entries resulting from Publicis Groupe sitting out the event and the organizers truncating the schedule.

A West Coast footprint and professional focus: Evoke's CEO on its Giant acquisition

A West Coast footprint and professional focus: Evoke's CEO on its Giant acquisition

Reid Connolly talks the benefits of buying San Francisco-based firm Giant.

Five things for pharma marketers to know: Friday, July 20, 2018

Five things for pharma marketers to know: Friday, July 20, 2018

More drugmakers vow to halt price increases; FDA considers allowing imported drugs in some cases; Trump administration examines rebates.

Healthcare takes blame for disappointing Q2 for Publicis Groupe

Healthcare takes blame for disappointing Q2 for Publicis Groupe

The holding company has launched a review of its Publicis Health Solutions business after a volatile Q2.

Five things for pharma marketers to know: Thursday, July 19, 2018

Five things for pharma marketers to know: Thursday, July 19, 2018

Healthcare decline weighs on Publicis Q2 earnings; Gottlieb releases biosimilar plan; Roche's lung cancer treatment shows positive results.

MM&M kicks off contest to find best places to work in healthcare marketing

MM&M kicks off contest to find best places to work in healthcare marketing

Being named among the MM&M Best Places to Work can help you stand out in the race for talent. Here's how the contest works.

Novartis' MS patent win also a win for Celgene's impending MS drug: analyst

Novartis' MS patent win also a win for Celgene's impending MS drug: analyst

Celgene's drug will now have time to establish itself in the market without generic competition.

Stelara highlights J&J's Q2 performance

Stelara highlights J&J's Q2 performance

The company posted a sales increase of 10.6% in the second quarter.

Five things for pharma marketers to know: Wednesday, July 18, 2018

Five things for pharma marketers to know: Wednesday, July 18, 2018

Novartis voluntarily halts price increases; Shkreli's former company considers name change; FDA issues guidance to modernize electronic health data in trials.

Publicis Health acquires Payer Sciences

Publicis Health acquires Payer Sciences

Payer Sciences is a health marketing agency that uses data and analytics to gather insights about payer behavior.

Study: Healthcare isn't as consumer centric as it wants to be

Study: Healthcare isn't as consumer centric as it wants to be

Prophet surveyed 240 healthcare organizations to find out where the industry is actually at on its shift to consumer centricity.

Omnicom healthcare revenue up 4.8% in Q2

Omnicom healthcare revenue up 4.8% in Q2

The holding company's overall revenue was up 1.8% in the period to $3.9 billion.

Five things for pharma marketers to know: Tuesday, July 17, 2018

Five things for pharma marketers to know: Tuesday, July 17, 2018

J&J beats expectations on Q2 earnings; AbbVie, Mylan sign U.S. license deal for Humira; Roche's new flu drug meets endpoints.

Huntsworth buys U.S. health shop Giant Creative Strategy for $72m

Huntsworth buys U.S. health shop Giant Creative Strategy for $72m

Huntsworth has continued its expansion by taking a majority stake in U.S. independent healthcare marketing agency Giant Creative Strategy for an initial sum of $72.2m.

Ketchum launches Vital Health, analytics-driven services for healthcare clients

Ketchum launches Vital Health, analytics-driven services for healthcare clients

Vital Health is driven by Ketchum's new analytics tool, Vital Diagnostics.

SapientRazorfish lays off staff amid rumors the brand will be eliminated

SapientRazorfish lays off staff amid rumors the brand will be eliminated

The Publicis-owned agency has laid off around 100 people in the U.S. alone this week

Ogilvy CommonHealth names Samantha Dolin creative chief

Ogilvy CommonHealth names Samantha Dolin creative chief

Dolin is overseeing offices in New York, New Jersey, Connecticut, and Canada.

Five things for pharma marketers to know: Monday, July 16, 2018

Five things for pharma marketers to know: Monday, July 16, 2018

MM&M Awards shortlist revealed; FDA approves first smallpox treatment; Another way Amazon could drive down healthcare costs.

The 2018 MM&M Awards: The Shortlist

The 2018 MM&M Awards: The Shortlist

Find out who made award-winning work this year.

Rockpointe launches medical education program on Amazon's Alexa

Rockpointe launches medical education program on Amazon's Alexa

Alexa could make it easier for doctors to squeeze CME programs into their busy schedules.

MedStar Health selects Doner as AOR

MedStar Health selects Doner as AOR

Doner will lead a branding effort for the health system that will roll out in 2019.

Pfizer reorg came on heels of its walk-back on price hikes

Pfizer reorg came on heels of its walk-back on price hikes

Wednesday's reorg was designed to position the company for growth in the face of the imminent patent cliff for megablockbuster Lyrica.

McCann Health terminates global CCO following employee complaint

McCann Health terminates global CCO following employee complaint

The agency said Jeremy Perrott violated the agency's code of conduct.

Five things for pharma marketers to know: Thursday, July 12, 2018

Five things for pharma marketers to know: Thursday, July 12, 2018

New report reveals large amount of opioids shipped to Missouri; Humana partners with Walgreens; Wyden requests details on Trump-Pfizer agreement

MediaMonks: The lowdown on the company that topped Sorrell's shopping list

MediaMonks: The lowdown on the company that topped Sorrell's shopping list

If you were unfamiliar with MediaMonks and want to know more about the company that Martin Sorrell has made his first capture, read on.

Ogilvy Worldwide creative chief fired after internal investigation

Ogilvy Worldwide creative chief fired after internal investigation

Tham Khai Meng has been with Ogilvy since 1999.

John Reid steps into SVP, executive creative role at Razorfish Health

John Reid steps into SVP, executive creative role at Razorfish Health

He's a veteran of Deep Focus, Wunderman, and ATTIK.

FDA wants clearer indications, usage language on product labels

FDA wants clearer indications, usage language on product labels

The government agency released its latest guidance this week.

Twitter purge of locked accounts welcomed by Unilever's Keith Weed

Twitter purge of locked accounts welcomed by Unilever's Keith Weed

Some Twitter accounts could lose millions of followers when the social platform purges large numbers of "locked" accounts this week.

Five things for pharma marketers to know: Wednesday, July 11, 2018

Five things for pharma marketers to know: Wednesday, July 11, 2018

Pfizer announces restructuring hours after about face on price hikes; Feds to slash funding for ACA "navigators"; Study finds rural states lag in combating heart disease.

Sorrell interview on MediaMonks' deal: 'You can celebrate for a nano-second'

Sorrell interview on MediaMonks' deal: 'You can celebrate for a nano-second'

In an interview with Campaign, Sir Martin Sorrell insisted his new company, S4 Capital, is listening to clients because they are "questioning" how agencies are delivering work.

Sorrell reveals 'very different approach' with $352.3m MediaMonks deal

Sorrell reveals 'very different approach' with $352.3m MediaMonks deal

Sir Martin Sorrell's S4 Capital has agreed to buy Dutch content business MediaMonks in a deal that is strikingly different from how he structured acquisitions at WPP.

Purdue's sales force targeted high prescribers with a 'false narrative,' unsealed lawsuit says

Purdue's sales force targeted high prescribers with a 'false narrative,' unsealed lawsuit says

Directing its reps to call on GPs with little to no opioid experience, Purdue introduced aggressive promotional tactics into the prescription opioid marketing playbook.

Did the market overreact to Biogen's Alzheimer's data?

Did the market overreact to Biogen's Alzheimer's data?

Biogen's recently soaring stock price can be attributed to investor optimism in one of the most stubborn areas of drug development.

Five things for pharma marketers to know: Tuesday, July 10, 2018

Five things for pharma marketers to know: Tuesday, July 10, 2018

CMS ends plan to make Novartis cancer treatment cheaper; Trump calls out Pfizer on Twitter for price hikes; News organizations sue to get federal opioid data.

Five Agency 100 things for pharma marketers to know: Monday, July 9, 2018

Five Agency 100 things for pharma marketers to know: Monday, July 9, 2018

The most comprehensive look at the pharma and healthcare agency world from MM&M.

Ashfield continues acquisition binge by snapping up Create NYC, SmartAnalyst

Ashfield continues acquisition binge by snapping up Create NYC, SmartAnalyst

The deals follow last year's additions of Cambridge BioMarketing and MicroMass Communications.

Five things for pharma marketers to know: Friday, July 6, 2018

Five things for pharma marketers to know: Friday, July 6, 2018

Positive Alzheimer's trial sends Biogen shares surging; A year after crisis, analysts come around to AstraZeneca stock; Ironwood cuts 40 jobs ahead of split.